Skip to content

Treasury Stock at other companies

McKesson logo
McKessonMCK
$32.01B+16.6%
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$61.43M+191%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$835.74M+37.3%
Opko Health logo
Opko HealthOPK
$1.79M0.0%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$43.52B-0.2%

Other financials

Income statement

See full
Revenue$147.4M+41.2%
Operating income-$6.5M+34.3%
Net income-$2.5M+87.3%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$30.3M-23.8%
Total debt$104.9M+2.5%
Total equity-$16.3M-421%
Total assets$168.2M+2.6%

Cash flow

See full
Operating cash flow-$2.2M+55.6%
CapEx$1.0M+218%
Free cash flow-$3.3M+38.7%

Valuation

See full
Market cap$511.91M+133%
Enterprise value$586.58M+108%
P/S0.9×+0.4×

Profitability

See full
Operating margin-6%-2.1pp
Net margin-8%-2.7pp
FCF margin-5.1%

Returns & leverage

See full
Return on equity-277.6%-700pp
Debt / equity20.2×+17.3×
Current ratio1.5×-0.3×

Where this comes from

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Oncology Institute, Inc.'s treasury stock?
The Oncology Institute, Inc. (TOI) reported treasury stock of $1.02M in Q1 2026.
How has The Oncology Institute, Inc.'s treasury stock changed year-over-year?
The Oncology Institute, Inc.'s treasury stock decreased by 0.0% year-over-year, from $1.02M to $1.02M.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.